Counterpulsation is a medical technique used to help the heart pump blood more effectively. It involves using a pump to help the heart during its resting phase, making it easier for the heart to fill up.
Every report comes from a Lived member, sent anonymously.
Have you had Counterpulsation for Stable Angina?
Counterpulsation helps the heart by pushing blood toward it while it relaxes between beats and releasing that pressure just as it pumps. The form most people encounter outside a hospital is enhanced external counterpulsation (EECP), a noninvasive outpatient treatment in which inflatable cuffs wrapped around the calves, thighs and buttocks squeeze in time with each heartbeat. The heart muscle gets much of its own blood supply during the relaxed phase, so squeezing blood back toward the chest at that moment increases flow to the heart. Releasing the cuffs just before the next beat lowers the pressure the heart has to pump against. EECP is used mainly for chronic angina, the chest pain or pressure caused by reduced blood flow to the heart muscle, when it still seriously limits everyday activity despite full medical treatment and the person is not a good candidate for more stents or bypass surgery. It is added to heart medicines and risk-factor care rather than replacing them. It has also been studied in chronic heart failure and other conditions, but the evidence there is thinner, and Medicare covers it only for severe stable angina. The word counterpulsation also covers the intra-aortic balloon pump, a hospital treatment in which a balloon on a thin tube is threaded through an artery, usually from the thigh, into the aorta (the body's main artery) to support a heart that cannot pump enough blood after a heart attack or in severe heart failure. That is a very different experience, with its own risks and a hospital stay. The rest of this page describes the outpatient leg-cuff treatment.
A cardiologist first confirms that the symptoms come from reduced blood flow to the heart, that medicines have been taken as far as they reasonably can, and that stents or bypass surgery are not suitable. Medicare covers the treatment only when the severity of the angina and the reasons surgery or stenting is not an option are documented. The evaluation also checks for conditions that make EECP unsafe or unlikely to work. Because the cuffs return extra blood to the heart and raise pressure in the arteries between beats, it is generally avoided with blood pressure above about 180/110 (either the top number over 180 or the bottom number over 110), heart failure that is not under control, or a very weak heart pump, meaning an ejection fraction (the share of blood the heart pushes out with each beat) below about 30%. Other reasons not to proceed include a moderate or severe leak in the aortic valve, an aortic aneurysm, severe artery disease in the legs, current or past blood clots in the leg veins or lungs, phlebitis or leg ulcers from poor circulation, severe chronic lung disease (COPD), irregular rhythms such as atrial fibrillation that prevent the cuffs from being timed to the heartbeat, and pregnancy. People who take warfarin usually need their INR (international normalized ratio, a blood test of how quickly blood clots) checked, since a value above 2 raises the chance of bruising and bleeding under the cuffs. Treatment is usually not started within two weeks of a cardiac catheterization or other artery puncture, so the puncture site can heal first. A full course means roughly 35 visits, so arranging transport and time around the schedule is a real part of getting ready.
Each session lasts about an hour. The cuffs are wrapped around the legs and buttocks, and a heart monitor (ECG) tracks each beat so a computer can time the cuffs. A sensor on a finger shows how much the pulse is being boosted, which lets the staff adjust timing and pressure. With every heartbeat the cuffs inflate in quick sequence from the calves upward, then all release at once as the heart contracts. The pressures used are high, so most people feel a firm, rhythmic squeeze moving up the legs that takes some getting used to. There are no needles, incisions or sedation, and a clinician supervises the treatment. A full course is usually 35 one-hour sessions, most often five days a week for about seven weeks. Some centers schedule two sessions on the same day to shorten the course.
Because nothing is inserted and no sedation is used, people can usually go about their day after each session. The legs may feel tired or sore, and skin under the cuffs can become red, chafed or bruised. Mention these early to the staff, who can adjust the cuffs or padding before a small skin problem becomes a sore that interrupts treatment. Any benefit builds over the course rather than after one session. The cardiologist usually reassesses angina, use of nitroglycerin (a fast-acting medicine for chest pain) and activity at the end. Heart medicines continue throughout and afterward. Studies following people after treatment suggest that improvement often lasts a year or two, but it fades for some people, and some centers offer a repeat course when symptoms return. Tell the care team promptly about new or worsening shortness of breath, swelling in the legs, or a calf that becomes painful, warm or swollen. For angina itself, keep following the chest pain plan you already have from your cardiologist.
EECP is generally well tolerated, and most side effects involve the legs: discomfort or pain, back pain, skin abrasion, bruising, blistering, swelling and tingling. In the main placebo-controlled trial, which compared full-pressure treatment with a low-pressure sham, these problems were noticeably more common with the real treatment, and some people stop the course early because of discomfort. Serious heart problems during treatment are uncommon and occur mostly in people at higher risk, which is why the screening described above matters: extra blood returned to the heart can worsen heart failure in a heart that is already struggling. The benefit is real for many people but less certain than for standard treatments. In that sham-controlled trial, real treatment delayed signs of strain on the heart during an exercise test, but did not clearly lengthen how long people could exercise or reduce their nitroglycerin use. Large registries report that about two in three people move to a less severe angina category, and pooled studies show less angina, less nitroglycerin use, longer walking distance and better quality of life. Much of that evidence comes from studies without a comparison group, the real treatment is hard to disguise, and people with diabetes may respond less. A course takes considerable time and does not reliably help everyone.
Last reviewed • Oct 2026
Educational content, not medical advice.
Share your experience with Counterpulsation, what to expect, or ask the community a question.